deos I’ve been averaging down there and loaded around 300 as the fundamentals show NCYT is worth 1000-1200 all day long with good revenue, profit & no debt. One to be patient on ;o)
I’ve worked for many US startups & the way they generate more shares is a stock split - while it doesn’t change the market cap it does give more to tie in key hires
I’ve seen many 4:1 & 5:1 stock splits so could we be looking at that here soon? Look at Oracle who’ve split their stock multiple times, 11 in fact, since 1989 & always a good thing!
“ Novacyt has sufficient manufacturing capacity to deliver more than three million antibody tests per month initially and the Company is working with its manufacturing partner to ensure this can be increased depending on demand.”